United States Biotechnology & Medical Research

Turn Therapeutics Inc (TTRX)

Track

Turn Therapeutics Inc. saw consistent insider buying activity between October and December 2025. Insiders, including Arthur F. Golden and Zuraiz Chaudhary, executed multiple purchase transactions during this period. The most recent trading activity occurred on December 12, 2025, with no further insider transactions reported in the last three months.
Ticker: TTRX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Turn Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
428.06
Quantity 169 -35.8%
Value US$4,869,563
3.4
GOLDEN ARTHUR F Non-Executive Director
Transaction date
Purchase
Price
446.42
Quantity 8,968 +24.2%
Value US$4,588,004
3.4
GOLDEN ARTHUR F Non-Executive Director
Transaction date
Purchase
Price
38.10
Quantity 14,908 +22.2%
Value US$4,839,736
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
3.29
Quantity 1,000 +11.1%
Value US$3,290
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
2.61
Quantity 1,450 +19.2%
Value US$3,784
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
3.62
Quantity 2,500 +49.5%
Value US$9,050
1.2
Chesed Abraham
Transaction date
Purchase
Price
4.60
Quantity 14,286 +1.0%
Value US$65,716
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
4.95
Quantity 5,050 +inf%
Value US$24,998
3.4
GOLDEN ARTHUR F Non-Executive Director
Transaction date
Purchase
Price
4.95
Quantity 20,202 +202.0%
Value US$100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-12 2025-12-12 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
169 -35.8%
428.06
US$4,869,563 		169 -35.8% 428.06 US$4,869,563
2025-11-25 2025-11-24 B Purchase
3.4
GOLDEN ARTHUR F
Non-Executive Director
8,968 +24.2%
446.42
US$4,588,004 		8,968 +24.2% 446.42 US$4,588,004
2025-11-24 2025-11-21 B Purchase
3.4
GOLDEN ARTHUR F
Non-Executive Director
14,908 +22.2%
38.10
US$4,839,736 		14,908 +22.2% 38.10 US$4,839,736
2025-11-21 2025-11-21 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
1,000 +11.1%
3.29
US$3,290 		1,000 +11.1% 3.29 US$3,290
2025-11-21 2025-11-20 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
1,450 +19.2%
2.61
US$3,784 		1,450 +19.2% 2.61 US$3,784
2025-11-17 2025-11-17 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
2,500 +49.5%
3.62
US$9,050 		2,500 +49.5% 3.62 US$9,050
2025-10-29 2025-10-23 B Purchase
1.2
Chesed Abraham
14,286 +1.0%
4.60
US$65,716 		14,286 +1.0% 4.60 US$65,716
2025-10-23 2025-10-23 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
5,050 +inf%
4.95
US$24,998 		5,050 +inf% 4.95 US$24,998
2025-10-23 2025-10-23 B Purchase
3.4
GOLDEN ARTHUR F
Non-Executive Director
20,202 +202.0%
4.95
US$100,000 		20,202 +202.0% 4.95 US$100,000
Explore more

More insider trading research around Turn Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America